Compounds > 2,4-thiazolidinedione
Page last updated: 2024-11-05

2,4-thiazolidinedione and Cancer of Pituitary

2,4-thiazolidinedione has been researched along with Cancer of Pituitary in 2 studies

thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.

Research Excerpts

ExcerptRelevanceReference
"Cushing's disease is associated with high morbidity and ultimately mortality."2.42PPAR-gamma in Cushing's disease. ( Heaney, AP, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heaney, AP2
Fernando, M1
Melmed, S1

Reviews

1 review available for 2,4-thiazolidinedione and Cancer of Pituitary

ArticleYear
PPAR-gamma in Cushing's disease.
    Pituitary, 2004, Volume: 7, Issue:4

    Topics: ACTH-Secreting Pituitary Adenoma; Adrenocorticotropic Hormone; Cushing Syndrome; Humans; Ligands; Ne

2004

Other Studies

1 other study available for 2,4-thiazolidinedione and Cancer of Pituitary

ArticleYear
PPAR-gamma receptor ligands: novel therapy for pituitary adenomas.
    The Journal of clinical investigation, 2003, Volume: 111, Issue:9

    Topics: Adenoma; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Apoptosis; Cell Separation;

2003